It’s a top selling drug that may not work. Simvastatin, which is also sold under the name Zocor, is supposed to help children with neurofibromatosis 1. It has been said that the drug will help “correct the learning and attention deficits” that kids with this genetic disorder experience.

According to studies conducted by a medical center in The Netherlands, 62 children part of their experient showed no improvement while taking the drug. Of course a sampling of these 62 children was given either a placebo or simvastatin during the three month duration. The results, published in the Journal of the American Medical Association this week, affirmed that this drug should no longer be recommended for improving the cognitive function of children with neurofibromatosis 1.

As with all medications there are side effects that may be unknown. If a drug like simvastatin was thought to be a drug that helps children with neurofibromatosis 1 and just recently has been proven that it has no affect, there is also no telling what drugs have been approved by the FDA but are actually harmful.

If you have had any adverse affects to a drug that you have been taking, it is important that you seek the medical attention you need, and secondly seek the proper legal consultation.

FDA
add, childrens drugs, Defective Drugs, FDA, neurofibromatosis, Simvastati